NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Cyclin-dependent kinase 8 (CDK8) regulates transcription and has oncogenic roles in various cancers.
• Natural killer (NK) cells are crucial for immune defense against transformed cells.
• Previous studies indicated CDK8 knockdown enhances NK cell cytotoxicity.

Purpose of the Study:

• To investigate the role of CDK8 in NK cell function and anti-tumor responses in vivo.
• To determine if inhibiting CDK8 can improve NK cell-mediated anti-tumor immunity.

Main Methods:

• Conditional ablation of CDK8 in NKp46+ cells in mice (Cdk8 mice).
• Assessment of NK cell development, maturation, perforin expression, and cytotoxicity in vitro.
• Evaluation of NK cell-mediated tumor surveillance in vivo using melanoma, lymphoma, and leukemia models.

Main Results:

• CDK8 deletion did not affect NK cell development or maturation.
• CDK8 ablation led to increased perforin expression and enhanced NK cell cytotoxicity in vitro.
• Inhibition of CDK8 improved NK cell-mediated tumor surveillance in vivo across three different cancer models.

Conclusions:

• CDK8 exerts a suppressive effect on NK cell activity.
• Targeting CDK8 may represent a therapeutic strategy to enhance NK cell-based anti-tumor immune responses in cancer patients.